Development code · Biologic
GSK4527223
GSK4527223 is a development code for Latozinemab, developed by Alector Inc..
- Status
- Discontinued for Frontotemporal dementia
- Mechanism
- Sortilin Antagonist
- Developer
- Alector Inc.
Programs
- Latozinemab for Frontotemporal dementiaDiscontinuedDiscontinued
- Latozinemab for Amyotrophic lateral sclerosisDiscontinuedDiscontinued
Also known as
- latozinemab
- AL001
- AL-001
- 2376132-27-1